ArticleIn vivo (Athens, Greece)

Pegfilgrastim Maintains Relative Dose Intensity and Decreases Hospitalisations in Patients With Endometrial Cancer.

Kenro Chikazawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.